chemieunternehmen.com

Evotec AG will report its financial results for the first nine months of 2017 on Wednesday, 08 November 2017.  Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-ag-to-report-first-nine-month-2017-results-on-08-november-2017-2

Evotec AG and TESARO, Inc. today announced a three-year integrated drug discovery collaboration to discover and develop novel small molecule product candidates against an undisclosed immuno-oncology (IO) target.  Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-tesaro-enter-strategic-partnership-to-discover-novel-immuno-oncology-agents-3

Evotec AG announced today that its strategic alliance with Celgene has reached a first milestone triggering revenues of $ 5.0 m to Evotec. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-achieves-first-milestone-in-neurodegeneration-alliance-with-celgene-4

Evotec AG and Exscientia Ltd („Exscientia“) today announced that Evotec has made a EUR 15 m investment to take a minority stake in Exscientia. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-invests-in-exscientia-to-advance-ai-driven-drug-discovery-5502

Evotec AG and MaRS Innovation („MI“) today announced the launch of „LAB150“. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-mars-innovation-establish-academic-bridge-lab150-in-toronto-5500

Evotec AG and the European Investment Bank („EIB“) announced today that the EIB has granted Evotec an unsecured loan facility of up to EUR 75 m to support Evotec’s Innovate strategy. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/european-investment-bank-supports-evotecs-innovate-strategy-with-eur-75-m-loan-5498

Evotec AG and ABIVAX today announced a strategic collaboration to discover and develop novel treatments for multiple serious viral infectious diseases. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-abivax-enter-into-strategic-collaboration-to-develop-novel-antiviral-agents-5496

Evotec AG today announced that, effective mid-August 2017, it has successfully completed the acquisition of Aptuit as announced in detail on 30 July 2017. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-completes-acquisition-of-aptuit-5492

Evotec AG today reported financial results and corporate updates for the first half of 2017. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-announces-first-half-year-2017-results-and-corporate-update-5490